Seattle Genetics

SGEN

SGEN
Seattle Genetics Stock Quote
$66.42 $0.40 0.6%
BATS BZX Real Time Price as of May 17, 2019, 4:30 p.m. View Interactive SGEN Charts

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.

News & Analysis: Seattle Genetics

The Fool has written over 100 articles on Seattle Genetics.

All

Market Moves

Earnings











Interactive Chart